Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa proof-of-concept study of KindaPed for head lice
ISRCTN66611560Phase 2Completed
- Sponsor
- EctoPharma
- Start
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of KindaPed in pediculosis capitis, sponsored by EctoPharma. Started Jun 2006; status: completed.
02
Drugs
KindaPed
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on ISRCTN66611560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66611560.